The Role Adjuvant Chemotherapy in Resected Stage 1 NSCLC with High Risk Factors: A Turkish Oncology Group Study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorEralp, Y.
dc.contributor.authorAk, N.
dc.contributor.authorYilmazbayhan, D.
dc.contributor.authorOzkan, B.
dc.contributor.authorFerhatoglu, F.
dc.contributor.authorDemirkazik, A.
dc.contributor.authorSak, S. Dizbay
dc.contributor.authorDilege, S.
dc.contributor.authorTanju, S.
dc.contributor.authorToker, A.
dc.contributor.authorBulutay, P.
dc.contributor.authorFirat, P.
dc.contributor.authorMandel, N. Molinas
dc.contributor.authorKilickap, S.
dc.contributor.authorOnder, S.
dc.contributor.authorDikmen, E.
dc.contributor.authorAlan, O.
dc.contributor.authorYumuk, P. F.
dc.contributor.authorBozkurtlar, E.
dc.contributor.authorLacin, T.
dc.contributor.authorOzturk, A.
dc.contributor.authorKocaturk, C.
dc.contributor.authorKarapinar, K.
dc.contributor.authorUrer, N.
dc.contributor.authorUluc, B. Oyan
dc.date.accessioned2023-02-21T12:40:20Z
dc.date.available2023-02-21T12:40:20Z
dc.date.issued2019-01-01
dc.description.issue10
dc.description.issueS
dc.description.pagesOCT
dc.description.volume14
dc.identifier.doi10.1016/j.jtho.2019.08.1934
dc.identifier.urihttps://hdl.handle.net/11443/2605
dc.identifier.urihttp://dx.doi.org/10.1016/j.jtho.2019.08.1934
dc.identifier.wosWOS:000492162204418
dc.relation.ispartofJOURNAL OF THORACIC ONCOLOGY
dc.titleThe Role Adjuvant Chemotherapy in Resected Stage 1 NSCLC with High Risk Factors: A Turkish Oncology Group Study
dc.typeArticle

Dosyalar

Orijinal seri

Şimdi gösteriliyor 1 - 1 / 1
Thumbnail Image
Ad:
The Role Adjuvant Chemotherapy in Resected Stage 1 NSCLC with High Risk Factors A Turkish.pdf
Boyut:
517.64 KB
Format:
Adobe Portable Document Format
İndir

Koleksiyonlar

WOS